Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

Circulating tenascin-C levels in patients with dilated cardiomyopathy in the course of Emery-Dreifuss muscular dystrophy.

Niebroj-Dobosz I, Madej-Pilarczyk A, Marchel M, Sokołowska B, Hausmanowa-Petrusewicz I.

Clin Chim Acta. 2011 Aug 17;412(17-18):1533-8. doi: 10.1016/j.cca.2011.04.033. Epub 2011 May 5.

PMID:
21596026
2.

Osteopontin--a fibrosis-related marker--in dilated cardiomyopathy in patients with Emery-Dreifuss muscular dystrophy.

Niebroj-Dobosz I, Madej-Pilarczyk A, Marchel M, Sokołowska B, Hausmanowa-Petrusewicz I.

Scand J Clin Lab Invest. 2011 Dec;71(8):658-62. doi: 10.3109/00365513.2011.619272.

PMID:
22077867
3.

Matrix metalloproteinases in serum of Emery-Dreifuss muscular dystrophy patients.

Niebroj-Dobosz I, Madej-Pilarczyk A, Marchel M, Sokołowska B, Hausmanowa-Petrusewicz I.

Acta Biochim Pol. 2009;56(4):717-22. Epub 2009 Dec 8.

4.

Higher serum tenascin-C levels reflect the severity of heart failure, left ventricular dysfunction and remodeling in patients with dilated cardiomyopathy.

Terasaki F, Okamoto H, Onishi K, Sato A, Shimomura H, Tsukada B, Imanaka-Yoshida K, Hiroe M, Yoshida T, Kitaura Y, Kitabatake A; Study Group for Intractable Diseases by a Grant from the Ministry of Health, Labor and Welfare of Japan.

Circ J. 2007 Mar;71(3):327-30.

5.

Tissue inhibitors of matrix metalloproteinases in serum are cardiac biomarkers in Emery-Dreifuss muscular dystrophy.

Niebroj-Dobosz IM, Sokołowska B, Madej-Pilarczyk A, Marchel M, Hausmanowa-Petrusewicz I.

Kardiol Pol. 2015;73(5):360-5. doi: 10.5603/KP.a2014.0243. Epub 2015 Jan 7.

6.

Incremental prognostic values of serum tenascin-C levels with blood B-type natriuretic peptide testing at discharge in patients with dilated cardiomyopathy and decompensated heart failure.

Fujimoto N, Onishi K, Sato A, Terasaki F, Tsukada B, Nozato T, Yamada T, Imanaka-Yoshida K, Yoshida T, Ito M, Hiroe M.

J Card Fail. 2009 Dec;15(10):898-905. doi: 10.1016/j.cardfail.2009.06.443. Epub 2009 Aug 26.

PMID:
19944367
7.

Circulating autoantibodies to troponin I in Emery-Dreifuss muscular dystrophy.

Niebroj-Dobosz I, Marchel M, Madej A, Sokolowska B, Hausmanowa-Petrusewicz I.

Acta Myol. 2008 Jul;27:1-6.

8.

Cardiac features of Emery-Dreifuss muscular dystrophy caused by lamin A/C gene mutations.

Sanna T, Dello Russo A, Toniolo D, Vytopil M, Pelargonio G, De Martino G, Ricci E, Silvestri G, Giglio V, Messano L, Zachara E, Bellocci F.

Eur Heart J. 2003 Dec;24(24):2227-36.

PMID:
14659775
9.

Evidence for autoimmunity to heart-specific antigens in patients with Emery-Dreifuss muscular dystrophy.

Niebroj-Dobosz I, Dorobek M, Marchel M, Hausmanowa-Petrusewicz I.

Acta Myol. 2006 Oct;25(2):68-72.

PMID:
18593007
10.

Echocardiographic assessment of left ventricular morphology and function in patients with Emery-Dreifuss muscular dystrophy.

Draminska A, Kuch-Wocial A, Szulc M, Zwolinska A, Styczynski G, Kostrubiec M, Hausmanowa-Petrusewicz I, Pruszczyk P.

Int J Cardiol. 2005 Jul 10;102(2):207-10.

PMID:
15982486
11.

Ventricular arrhythmia in X-linked Emery-Dreifuss muscular dystrophy: a lesson from an autopsy case.

Ishikawa K, Mimuro M, Tanaka T.

Intern Med. 2011;50(5):459-62. Epub 2011 Mar 1.

12.

Clinical and molecular genetic spectrum of autosomal dominant Emery-Dreifuss muscular dystrophy due to mutations of the lamin A/C gene.

Bonne G, Mercuri E, Muchir A, Urtizberea A, Bécane HM, Recan D, Merlini L, Wehnert M, Boor R, Reuner U, Vorgerd M, Wicklein EM, Eymard B, Duboc D, Penisson-Besnier I, Cuisset JM, Ferrer X, Desguerre I, Lacombe D, Bushby K, Pollitt C, Toniolo D, Fardeau M, Schwartz K, Muntoni F.

Ann Neurol. 2000 Aug;48(2):170-80.

PMID:
10939567
13.

[The first Japanese case of autosomal dominant Emery-Dreifuss muscular dystrophy with a novel mutation in the lamin A/C gene].

Onishi Y, Higuchi J, Ogawa T, Namekawa A, Hayashi H, Odakura H, Goto K, Hayashi YK.

Rinsho Shinkeigaku. 2002 Feb;42(2):140-4. Japanese.

PMID:
12424964
14.

P-wave duration and dispersion in patients with Emery-Dreifuss muscular dystrophy.

Russo V, Rago A, Palladino A, Papa AA, Di Meo F, Della Cioppa N, Golino P, Russo MG, Calabrò R, Politano L, Nigro G.

J Investig Med. 2011 Oct;59(7):1151-4. doi: 10.2310/JIM.0b013e31822cf97a.

PMID:
22011621
15.

Emery-Dreifuss muscular dystrophy - a 40 year retrospective.

Emery AE.

Neuromuscul Disord. 2000 Jun;10(4-5):228-32. Review.

PMID:
10838246
16.

Serum tenascin-C levels as a prognostic biomarker of heart failure events in patients with hypertrophic cardiomyopathy.

Kitaoka H, Kubo T, Baba Y, Yamasaki N, Matsumura Y, Furuno T, Doi YL.

J Cardiol. 2012 Mar;59(2):209-14. doi: 10.1016/j.jjcc.2011.11.008. Epub 2012 Jan 2.

17.

Heart transplantation in patients with Emery-Dreifuss muscular dystrophy: case reports.

Dell'Amore A, Botta L, Martin Suarez S, Lo Forte A, Mikus E, Camurri N, Ortelli L, Arpesella G.

Transplant Proc. 2007 Dec;39(10):3538-40.

PMID:
18089432
18.

Cardiac transplantation in twins with autosomal dominant Emery-Dreifuss muscular dystrophy.

Kichuk Chrisant MR, Drummond-Webb J, Hallowell S, Friedman NR.

J Heart Lung Transplant. 2004 Apr;23(4):496-8.

PMID:
15063412
19.

Missense mutations in the rod domain of the lamin A/C gene as causes of dilated cardiomyopathy and conduction-system disease.

Fatkin D, MacRae C, Sasaki T, Wolff MR, Porcu M, Frenneaux M, Atherton J, Vidaillet HJ Jr, Spudich S, De Girolami U, Seidman JG, Seidman C, Muntoni F, Müehle G, Johnson W, McDonough B.

N Engl J Med. 1999 Dec 2;341(23):1715-24.

20.

Emery-Dreifuss dystrophy: a 4-year follow-up on a laminopathy of special interest.

Hausmanowa-Petrusewicz I, Madej-Pilarczyk A, Marchel M, Opolski G.

Neurol Neurochir Pol. 2009 Sep-Oct;43(5):415-20.

PMID:
20054742

Supplemental Content

Support Center